Global Metagenomic Sequencing Market
Healthcare Services

What Is The Forecast Growth Rate For The Metagenomic Sequencing Market?

The Business Research Company’s market reports offer an in-depth analysis on the market’s growth potential, major drivers, key trends and more.

Rapid Market Expansion

  • Current Market Size: The metagenomic sequencing market has seen significant growth, increasing from $1.82 billion in 2023 to an estimated $2.13 billion in 2024, at a CAGR of 16.9%.
  • Historic Growth Factors: Key drivers include government involvement, rising metagenome sequencing research projects, and advancements in genomics and diagnostics research. Additionally, research funding and the development of Next-Generation Sequencing (NGS) data analysis tools have played crucial roles.

Future Market Projections

  • Future Market Size: The market is expected to grow to $4.02 billion by 2028, with a CAGR of 17.2%.
  • Forecast Growth Factors: Factors driving future growth include decreasing computational costs, a focus on discovering novel biomolecules, the increasing adoption of high-throughput sequencing technologies, and the growing demand for personalized medicine and disease diagnosis. The prevalence of infectious diseases also contributes to market expansion.

Read More On The Metagenomic Sequencing Market Report 2024 – https://www.thebusinessresearchcompany.com/report/metagenomic-sequencing-global-market-report

Drivers of Market Growth

Rising Prevalence of Infectious Diseases

  • Infectious Diseases: Disorders caused by pathogenic microorganisms, such as bacteria, viruses, parasites, or fungi, are driving the demand for metagenomic sequencing.
  • Immune System Conditions: Conditions like HIV/AIDS, cancer treatments, and autoimmune disorders increase susceptibility to infectious diseases.
  • Metagenomic Sequencing: This technology offers insights into pathogen diversity, transmission dynamics, antimicrobial resistance, and outbreak surveillance.
    • HIV Statistics: According to UNAIDS, the global HIV population exceeded 39 million in 2023.
    • TB Cases: The CDC reported a 5.9% increase in tuberculosis cases in the US from 2021 to 2022.

Major Companies in the Metagenomic Sequencing Market

Leading Companies

  • Key Players: Major companies include F. Hoffmann-La Roche Ltd., Thermo Fisher Scientific Inc., Merck Co. & KGaA, Eurofins Scientific SE, PerkinElmer Inc., Illumina Inc., Bio-Rad Laboratories Inc., QIAGEN N.V., Beijing Genomics Institute Group, and others.

Innovation in Sequencing Services

  • Advanced Technologies: Companies are innovating to improve sequencing accuracy, throughput, and cost-effectiveness.
  • Clinical Microbiomics A/S: In April 2024, they launched advanced long-read sequencing services, enhancing microbial analysis and metagenome-assembled genomes.

Notable Acquisitions

Illumina Inc. and IDbyDNA

  • Acquisition Details: In January 2022, Illumina Inc. acquired IDbyDNA, a company specializing in metagenomic technologies for pathogen surveillance and infectious illness testing.
  • Strategic Integration: This acquisition aims to strengthen Illumina’s capabilities in infectious disease diagnostics and microbial genomics.

Market Segmentation

Product and Service Segmentation

  • Categories: The market is segmented by products and services including reagents and consumables, instruments, sequencing services, and analysis and data interpretation solutions.

Technological Segmentation

  • Technologies: Includes 16S rRNA sequencing, shotgun metagenomic sequencing, whole-genome sequencing and de novo assembly, and metatranscriptomics.

Application Segmentation

  • Applications: Covers clinical diagnostics, environmental remediation, gut microbe characterization, drug discovery, biofuel, agriculture, and other applications.

Regional Insights

Largest and Fastest Growing Regions

  • North America: Dominated the metagenomic sequencing market in 2023.
  • Asia-Pacific: Expected to be the fastest-growing region in the coming years.

The metagenomic sequencing market is poised for substantial growth, driven by advancements in technology, increasing research initiatives, and rising demand for personalized medicine and effective disease diagnosis.

Request for A Sample Of The Global Metagenomic Sequencing Market Report:
https://www.thebusinessresearchcompany.com/sample_request?id=16117&type=smp